Attached files
| file | filename |
|---|---|
| EX-21.1 - VBI Vaccines Inc/BC | ex21-1.htm |
| 10-K - VBI Vaccines Inc/BC | form10-k.htm |
| EX-32.2 - VBI Vaccines Inc/BC | ex32-2.htm |
| EX-32.1 - VBI Vaccines Inc/BC | ex32-1.htm |
| EX-31.2 - VBI Vaccines Inc/BC | ex31-2.htm |
| EX-31.1 - VBI Vaccines Inc/BC | ex31-1.htm |
| EX-23.1 - VBI Vaccines Inc/BC | ex23-1.htm |
| EX-10.59 - VBI Vaccines Inc/BC | ex10-59.htm |
| EX-10.58 - VBI Vaccines Inc/BC | ex10-58.htm |
| EX-10.57 - VBI Vaccines Inc/BC | ex10-57.htm |
| EX-10.56 - VBI Vaccines Inc/BC | ex10-56.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of VBI Vaccines, Inc. and subsidiaries on Form S-3 (No. 333-217995) of our report dated March 20, 2017, on our audit of the consolidated financial statements as of December 31, 2015 and for the year then ended, which report is included in this Annual Report on Form 10-K to be filed on or about February 23, 2018.
/s/ Smythe LLP
Chartered Professional Accountants
Vancouver, Canada
February 26, 2018